Blarcamesine: An Investigational Oral Drug for Alzheimer Disease cover art

Blarcamesine: An Investigational Oral Drug for Alzheimer Disease

Blarcamesine: An Investigational Oral Drug for Alzheimer Disease

Listen for free

View show details

About this listen

 Timo Grimmer, MD, Associate Professor of Psychiatry and Psychotherapy and Head of the Centre for Cognitive Disorders at the Technical University of Munich, Germany, discusses the experimental oral small molecule drug blarcamesine, which is under investigation as a potential treatment for Alzheimer disease. Learn more about your ad choices. Visit megaphone.fm/adchoices
No reviews yet
In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.